Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)

Clinical trial NCT00079976 · COMPLETED

Trial details

NCT number: NCT00079976
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gram-Positive Bacterial Infections Staphylococcus Infections Vancomycin Resistance Methicillin Resistance

Start date: 2003-10-01
Primary completion: 2005-06-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.